vs
Side-by-side financial comparison of MFA FINANCIAL, INC. (MFA) and STEM, INC. (STEM). Click either name above to swap in a different company.
MFA FINANCIAL, INC. is the larger business by last-quarter revenue ($55.5M vs $47.1M, roughly 1.2× STEM, INC.). On growth, MFA FINANCIAL, INC. posted the faster year-over-year revenue change (9.2% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 7.7%).
MFA Financial, Inc. is a U.S.-headquartered real estate investment trust (REIT) specializing in investing in and managing residential and commercial mortgage-backed securities, mortgage loans, and other real estate-related financial assets. It caters primarily to institutional and individual investors across the U.S., focusing on delivering stable risk-adjusted returns via rigorous asset screening and risk management frameworks.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
MFA vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.5M | $47.1M |
| Net Profit | — | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | 97.9% | -17.7% |
| Net Margin | — | -33.9% |
| Revenue YoY | 9.2% | -15.6% |
| Net Profit YoY | — | 68.8% |
| EPS (diluted) | $0.43 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $55.5M | $47.1M | ||
| Q3 25 | $56.8M | $38.2M | ||
| Q2 25 | $61.3M | $38.4M | ||
| Q1 25 | $57.5M | $32.5M | ||
| Q4 24 | $50.8M | $55.8M | ||
| Q3 24 | $50.6M | $29.3M | ||
| Q2 24 | $53.5M | $34.0M | ||
| Q1 24 | $47.8M | $25.5M |
| Q4 25 | — | $-16.0M | ||
| Q3 25 | $48.1M | $-23.8M | ||
| Q2 25 | $33.2M | $202.5M | ||
| Q1 25 | $41.2M | $-25.0M | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | $48.2M | $-148.3M | ||
| Q2 24 | $41.9M | $-582.3M | ||
| Q1 24 | $23.2M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | 97.9% | -17.7% | ||
| Q3 25 | 84.5% | -33.6% | ||
| Q2 25 | 54.5% | -34.8% | ||
| Q1 25 | 70.0% | -65.0% | ||
| Q4 24 | 6.8% | -84.4% | ||
| Q3 24 | 98.2% | -493.2% | ||
| Q2 24 | 79.1% | -1705.5% | ||
| Q1 24 | 50.7% | -267.0% |
| Q4 25 | — | -33.9% | ||
| Q3 25 | 84.7% | -62.2% | ||
| Q2 25 | 54.2% | 527.8% | ||
| Q1 25 | 71.6% | -76.9% | ||
| Q4 24 | — | -91.6% | ||
| Q3 24 | 95.2% | -506.3% | ||
| Q2 24 | 78.4% | -1712.6% | ||
| Q1 24 | 48.5% | -283.9% |
| Q4 25 | $0.43 | $-4.40 | ||
| Q3 25 | $0.35 | $-2.84 | ||
| Q2 25 | $0.21 | $-1.79 | ||
| Q1 25 | $0.31 | $-0.15 | ||
| Q4 24 | $-0.01 | $-15.29 | ||
| Q3 24 | $0.37 | $-18.24 | ||
| Q2 24 | $0.32 | $-71.81 | ||
| Q1 24 | $0.14 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $213.2M | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.8B | $-249.4M |
| Total Assets | $13.0B | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $213.2M | $48.9M | ||
| Q3 25 | $305.2M | $43.1M | ||
| Q2 25 | $275.7M | $40.8M | ||
| Q1 25 | $253.7M | $58.6M | ||
| Q4 24 | $338.9M | $56.3M | ||
| Q3 24 | $305.6M | $75.4M | ||
| Q2 24 | $289.4M | $89.6M | ||
| Q1 24 | $306.3M | $112.8M |
| Q4 25 | $1.8B | $-249.4M | ||
| Q3 25 | $1.8B | $-235.7M | ||
| Q2 25 | $1.8B | $-214.1M | ||
| Q1 25 | $1.8B | $-417.5M | ||
| Q4 24 | $1.8B | $-398.4M | ||
| Q3 24 | $1.9B | $-344.1M | ||
| Q2 24 | $1.9B | $-203.2M | ||
| Q1 24 | $1.9B | $371.6M |
| Q4 25 | $13.0B | $308.9M | ||
| Q3 25 | $12.1B | $362.6M | ||
| Q2 25 | $11.7B | $379.2M | ||
| Q1 25 | $11.5B | $405.1M | ||
| Q4 24 | $11.4B | $437.4M | ||
| Q3 24 | $11.2B | $537.8M | ||
| Q2 24 | $11.1B | $691.5M | ||
| Q1 24 | $10.9B | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $76.2M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $76.2M | $8.2M | ||
| Q3 25 | $14.7M | $11.4M | ||
| Q2 25 | $38.5M | $-21.3M | ||
| Q1 25 | $-14.6M | $8.5M | ||
| Q4 24 | $200.1M | $-14.7M | ||
| Q3 24 | $-11.3M | $-9.4M | ||
| Q2 24 | $46.5M | $-11.9M | ||
| Q1 24 | $53.5M | $-621.0K |
| Q4 25 | — | — | ||
| Q3 25 | 0.31× | — | ||
| Q2 25 | 1.16× | -0.11× | ||
| Q1 25 | -0.35× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.23× | — | ||
| Q2 24 | 1.11× | — | ||
| Q1 24 | 2.30× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
